Skip to content

Research on Optimizing Anesthesia Strategies and Early Warning of Bleeding Risks in Laparoscopic Hepatectomy Based on Dynamic Regulation of SVV and SVRI

Research on Optimizing Anesthesia Strategies and Early Warning of Bleeding Risks in Laparoscopic Hepatectomy Based on Dynamic Regulation of SVV and SVRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121019
Enrollment
Unknown
Registered
2026-03-24
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease

Interventions

intervention group:Goal-oriented optimization of anesthesia strategy
control group:Conventional hemodynamic management

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18~70, gender is not limited; 2.The American Society of Anesthesiologists (ASA) classification is graded from I to III; 3.The Child-Pugh classification of liver function is Grade A or B; 4.Elective first laparoscopic hepatectomy; 5.Preoperative assessment showed that the patient's heart, lung, and kidney functions were basically normal, and the patient was able to tolerate surgery and anesthesia; 6.The patient or their legal guardian fully understands the content of this study and voluntarily signs the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Preoperative severe dysfunction or failure of vital organs such as the heart, lungs, brain, and kidneys; 2.Preoperative coagulation dysfunction or long-term use of anticoagulant and antiplatelet drugs, and failure to discontinue medication until the safe window period before surgery; 3.There is severe arrhythmia, such as high-degree atrioventricular block, sick sinus syndrome, etc., or preoperative heart rate <50 beats per minute; 4.There is severe stenosis or occlusion of peripheral arteries, making it impossible to accurately monitor invasive arterial pressure and related hemodynamic parameters; 5.Due to changes in the patient's condition during the operation, a conversion to open surgery was necessary; 6.Emergency surgery, re-hepatectomy, or combined resection of other organs; 7.Pregnant or lactating women; 8.Individuals known to be allergic to the anesthetic drugs used in this study; 9.The patient refused to participate or was unable to cooperate in completing the study;

Design outcomes

Primary

MeasureTime frame
Hemodynamic indicators:Heart rate (HR), mean arterial pressure (MAP)Stroke Volume Variability (SVV), Systemic Vascular Resistance Index (SVRI), Cardiac Index (CI), Stroke Volume Index (SVI);

Secondary

MeasureTime frame
Liver function and kidney function;tissue perfusion;Bleeding and transfusion-related indicators:Total intraoperative blood loss (ml), blood loss rate per unit time (ml/h), autologous blood transfusion rate (%), total volume of allogeneic blood transfusion (ml), and allogeneic blood transfusion r;postoperative complications;Total postoperative hospitalization days;The first time of getting out of bed after surgery;

Countries

China

Contacts

Public ContactShen Xu

The First Hospital of Jiaxing

fishsx0321@sina.com+86 573 8359 9078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026